{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:39:20Z","timestamp":1792215560209,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.radonc.2022.10.034","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T12:25:40Z","timestamp":1667478340000},"page":"105-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose\u2013volume constraints with long-term endocrine outcomes"],"prefix":"10.1016","volume":"177","author":[{"given":"James C.H.","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.F.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Man","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H.P.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.C.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Y.S.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis K.H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex K.C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Hung","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Tong","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W.M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Kong","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry H.Y.","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.10.034_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2011.03.002","article-title":"Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review","volume":"99","author":"Boomsma","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0010","first-page":"83","article-title":"Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: a systematic review","volume":"33","author":"Chow","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tcm.2019.02.011","article-title":"Subclinical thyroid dysfunction and cardiovascular consequences: an alarming wake-up call?","volume":"30","author":"Manolis","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.radonc.2022.10.034_b0020","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0025","unstructured":"National Comprehensive Cancer Network. Head and Neck Cancers (Version 1.2022). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed March 7, 2022."},{"key":"10.1016\/j.radonc.2022.10.034_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.104444","article-title":"Radiation induced hypothyroidism - why is early intervention necessary?","volume":"103","author":"Aggarwal","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","article-title":"International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma","volume":"105","author":"Lee","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.10.034_b0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2018.08.018","article-title":"Revisiting the dose constraints for head and neck OARs in the current era of IMRT","volume":"86","author":"Brodin","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0045","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijrobp.2009.05.018","article-title":"Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer","volume":"77","author":"Diaz","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.10.034_b0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jjco\/hyt235","article-title":"Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer","volume":"44","author":"Kim","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0055","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/hed.23482","article-title":"Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials","volume":"36","author":"Murthy","year":"2014","journal-title":"Head and Neck"},{"key":"10.1016\/j.radonc.2022.10.034_b0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1748-717X-9-104","article-title":"V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck","volume":"9","author":"Akgun","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13014-014-0269-4","article-title":"Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy","volume":"9","author":"Chyan","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jrr\/rrv006","article-title":"The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases","volume":"56","author":"Fujiwara","year":"2015","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2022.10.034_b0075","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/j.clon.2016.05.004","article-title":"Dosimetric predictors of hypothyroidism after radical intensity-modulated radiation therapy for non-metastatic nasopharyngeal carcinoma","volume":"28","author":"Lee","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2022.10.034_b0080","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hed.24643","article-title":"Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation","volume":"39","author":"Ling","year":"2017","journal-title":"Head and Neck"},{"key":"10.1016\/j.radonc.2022.10.034_b0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/COC.0000000000000165","article-title":"Thyroid V50 highly predictive of hypothyroidism in head-and-neck cancer patients treated with intensity-modulated radiotherapy (IMRT)","volume":"40","author":"Sachdev","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.oraloncology.2017.03.005","article-title":"Radiation-induced hypothyroidism after IMRT for nasopharyngeal carcinoma: clinical and dosimetric predictors in a prospective cohort study","volume":"68","author":"Zhai","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ijrobp.2017.03.007","article-title":"Thyroid V40 predicts primary hypothyroidism after intensity modulated radiation therapy for nasopharyngeal carcinoma","volume":"98","author":"Sommat","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.10.034_b0100","first-page":"6126","article-title":"A dosimetric study on radiation-induced hypothyroidism following intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma","volume":"16","author":"Xu","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.radonc.2022.10.034_b0105","doi-asserted-by":"crossref","first-page":"e0200310","DOI":"10.1371\/journal.pone.0200310","article-title":"Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2022.10.034_b0110","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jrr\/rry036","article-title":"Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a phase III randomized trial","volume":"59","author":"Lertbutsayanukul","year":"2018","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2022.10.034_b0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jnci.2018.01.004","article-title":"Radiotherapeutic factors affecting the incidence of developing hypothyroidism after radiotherapy for head and neck squamous cell cancer","volume":"30","author":"El-Shebiney","year":"2018","journal-title":"J Egypt Natl Canc Inst"},{"key":"10.1016\/j.radonc.2022.10.034_b0120","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1002\/cam4.2574","article-title":"Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-a single-institution study","volume":"8","author":"Huang","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2022.10.034_b0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.meddos.2018.02.001","article-title":"Postradiation hypothyroidism in head and neck cancers: a department of veterans affairs single-institution case-control dosimetry study","volume":"44","author":"Lin","year":"2019","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2022.10.034_b0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13014-020-01490-x","article-title":"Thyroid V50 is a risk factor for hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a retrospective study","volume":"15","author":"Zhou","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.551255","article-title":"A new model for predicting hypothyroidism after intensity-modulated radiotherapy for nasopharyngeal carcinoma","volume":"10","author":"Peng","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2018.09.007","article-title":"Competing risks in survival data analysis","volume":"130","author":"Dutz","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12874-017-0332-6","article-title":"Time-dependent ROC curve analysis in medical research: current methods and applications","volume":"17","author":"Kamarudin","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.radonc.2022.10.034_b0150","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ijrobp.2007.01.029","article-title":"Primary and central hypothyroidism after radiotherapy for head-and-neck tumors","volume":"68","author":"Bhandare","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.10.034_b0155","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00405-011-1504-3","article-title":"The incidence of thyroid dysfunction following radiotherapy for early stage carcinoma of the larynx","volume":"268","author":"Kumar","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.radonc.2022.10.034_b0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gregoire","year":"2018","journal-title":"TROG consensus guidelines Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.10.034_b0170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1470-2045(22)00058-4","article-title":"Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial","volume":"23","author":"Tang","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022045297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022045297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:22:37Z","timestamp":1759123357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022045297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":34,"alternative-id":["S0167814022045297"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.10.034","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose\u2013volume constraints with long-term endocrine outcomes","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}